glp-1 needles New Guidelines on Drugs for Obesity Released What to do if you

Despite the claims, Abbott and Mead Johnson deny the allegations, arguing that their products are thoroughly researched and dismissing the scientific evidence linking their formulas to NEC, while the FDA issued a warning to Abbott regarding safety concerns of a formula product

Who is a good candidate for glp-1

Before prescribing, clinicians should confirm appropriate indicationseither inadequately controlled type 2 diabetes or obesity with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities such as hypertension or dyslipidemia)

[1] The medication's mechanism of action involves simultaneous activation of two incretin hormone pathways